kresmion.
Pull a receipt
PREVIEW · SAMPLE DATA
This is the ALZN dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for ALZN.

ALZN

Alzamend Neuro, Inc.
Healthcare · Biotechnology
$275.45 sample
+3.47 (+1.28%) 1D
☆ Watch
Market cap
$919.1B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-14
Alerts
8
Price$275.45 +16.12% 3M daily closessample
275.45237.22
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 20INSInsider buy: 10% owner
  • Oct 14SEC10-Q filed
  • Oct 07INSInsider sell: 10% owner
  • Sep 28SECDEF 14A filed
  • Sep 22INSInsider sell: Director
  • Sep 14INSInsider buy: Chief Financial Officer
  • Sep 04INSInsider buy: General Counsel
  • Aug 31SEC10-Q filed
Sign up to see the real ALZN record →

Company facts

SEC EDGAR registration
Name
Alzamend Neuro, Inc.
Sector
Healthcare
Industry
Biotechnology
Smart-money score
+58sample, -100 to +100
Reporting currency
USD

Who is positioning in ALZN

sample
Insiders
23 insider transactions over 90 days, net selling, $575.1M
Congress
1 members traded over 90 days
Institutions · 13F
32 funds hold $13.3B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$55.1B +12.4% y/y
Q4 2024Q3 2026
Inventory$35.1B +18.1% y/y
Q4 2024Q3 2026
Accounts receivable$25.3B +9.2% y/y
Q4 2024Q3 2026
Total debt$68.6B +18.6% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$519.4B +1.1% 3M
Sample peer B
$199.2B +0.7% 3M
Sample peer C
$550.2B +3.9% 3M
Sample peer D
$700.3B +14.2% 3M
Sample peer E
$476.9B -10.5% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not ALZN's real figure. Nothing here is investment advice.